Sign In
Learn bits
Science & Tech.
Komal gupta

24/02/22 13:20 PM IST

Source: PIB

CORBEVAX

In News

CORBEVAXTM is India’s first indigenously developed receptor binding domain protein sub-unit vaccine for COVID-19.

About the Vaccine:

  • This is developed by Biological E Limited with the support of the Department of Biotechnology and Biotechnology Industry Research Assistance Council (BIRAC). 
  • It is a recombinant protein vaccine which uses the receptor binding domain of the spike protein on the viral surface. 
  • It is a double dose vaccine that is administered intramuscularly and stored at 2° C to 8° C.

More Related Current Affairs View All

17 Sep

Reasons Behind the heavy rain in Uttarakhand, Himachal

'Dehradun and several other districts in Uttarakhand have experienced very heavy rainfall over the past few days, triggering landslides in multiple areas and causing rivers to swel

Read More

08 Sep

Rajasthan’s coaching centre Bill

'The Rajasthan Coaching Centres (Control and Regulation) Bill, 2025, is a significant piece of legislation passed by the Rajasthan Assembly to regulate and oversee the state's burg

Read More

28 Aug

IADT-1

'Recently, the Indian Space Research Organisation (ISRO) successfully carried out its first Integrated Air Drop Test (IADT-1), a crucial milestone in the preparation for the countr

Read More

India’s First Ai-Driven Magazine Generator

Generate Your Custom Current Affairs Magazine using our AI in just 3 steps